Wang, Qiao <br/><br/>
Utility of Targeted, Amplicon-Based Deep Sequencing To Detect Resistance to First-Line Tuberculosis Drugs in Botswana.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  11 2019 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.00982-19  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antitubercular Agents--therapeutic use<br/>Botswana<br/>Female<br/>High-Throughput Nucleotide Sequencing--methods<br/>Humans<br/>Isoniazid--therapeutic use<br/>Male<br/>Microbial Sensitivity Tests--methods<br/>Middle Aged<br/>Mycobacterium tuberculosis--drug effects<br/>Phenotype<br/>Sensitivity and Specificity<br/>Tuberculosis, Multidrug-Resistant--drug therapy<br/>Young Adult